Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 February 2007, Vol. 109, No. 4, pp. 1736-1742.
Prepublished online as a Blood First Edition Paper on October 10, 2006; DOI 10.1182/blood-2006-03-010413.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-03-010413v1
109/4/1736    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dumble, M.
Right arrow Articles by Donehower, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumble, M.
Right arrow Articles by Donehower, L. A.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Apoptosis
Right arrow Cell Cycle
Right arrow Free Research Articles
Right arrow Stem Cells in Hematology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

STEM CELLS IN HEMATOLOGY

The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging

Melissa Dumble1, Lynette Moore2, Stuart M. Chambers3,4, Hartmut Geiger5, Gary Van Zant6, Margaret A. Goodell3,4,7,8, and Lawrence A. Donehower1,3

Departments of1 Molecular Virology and Microbiology, 2 Molecular and Cellular Biology, 3 Interdepartmental Program in Cell and Molecular Biology, 4 Center for Cell and Gene Therapy, 7 Pediatrics, and 8 Immunology, Baylor College of Medicine, Houston, TX; 5 Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, OH; 6 Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY

A temporal decline in tissue stem cell functionality may be a key component of mammalian aging. The tumor suppressor p53 has recently been implicated as a potential regulator of aging. We examined age-associated hematopoietic stem cell (HSC) dynamics in mice with varying p53 activities. Reduced p53 activity in p53+/– mice was associated with higher numbers of proliferating hematopoietic stem and progenitor cells in old age compared with aged wild-type (p53+/+) mice. We also assessed HSC dynamics in a p53 mutant mouse model (p53+/m) with higher apparent p53 activity than wild-type mice. The p53 hypermorphic (p53+/m) mice display phenotypes of premature aging. Many aged p53+/m organs exhibit reduced cellularity and atrophy, suggesting defects in stem-cell regenerative capacity. HSC numbers from old p53+/m mice fail to increase with age, unlike those of their p53+/+ and p53+/– counterparts. Moreover, transplantation of 500 HSCs from old p53+/m mice into lethally irradiated recipients resulted in reduced engraftment compared with old wild-type p53+/+ and p53+/– HSCs. Thus, alteration of p53 activity affects stem-cell numbers, proliferation potential, and hematopoiesis in older organisms, supporting a model in which aging is caused in part by a decline in tissue stem cell regenerative function.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GeneticsHome page
H. Zetterberg, M. Bath, M. Zetterberg, P. Bernhardt, and O. Hammarsten
The Szilard Hypothesis on the Nature of Aging Revisited
Genetics, May 1, 2009; 182(1): 3 - 9.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Matheu, A. Maraver, and M. Serrano
The Arf/p53 Pathway in Cancer and Aging
Cancer Res., August 1, 2008; 68(15): 6031 - 6034.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
F. Rodier, J. Campisi, and D. Bhaumik
Two faces of p53: aging and tumor suppression
Nucleic Acids Res., December 3, 2007; 35(22): 7475 - 7484.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Feng, W. Hu, A. K. Teresky, E. Hernando, C. Cordon-Cardo, and A. J. Levine
Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older populations
PNAS, October 16, 2007; 104(42): 16633 - 16638.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020